Abstract

It has been suggested that the binding of angiotensin II to AT1 receptors activates a cascade of events that leads to stimulation of oxidative stress, the products of which possess remarkable vasoconstrictive qualities. The major enzyme-producing oxidative radical is the enzymatic complex NADPH-oxidase. The effect of angiotensin II on activation of NADPH-oxidase in monocyte and granulocyte from normotensive volunteers and the signaling pathways leading to its activity were investigated. Angiotensin II stimulated a dose-dependent activation of NADPH oxidase in both peripheral blood monocytes and granulocytes, with higher activity obtained in monocytes. Similarly, a dose-dependent activation of NADPH oxidase was demonstrated in the myeloid cell-line PLB-985 differentiated towards neutrophil or monocyte lineages, with higher efficiency observed in the monocytic-like cells. The selective AT1 receptor antagonist, losartan, inhibited NADPH-oxidase activity stimulated by angiotensin II. A high correlation between phospholipase A2 and NADPH-oxidase activities were obtained in angiotensin II-stimulated monocytes, neutrophils or differentiated PLB-985 cells. These results are in accordance with our previous studies demonstrating the essential requirement of cytosolic phospholipase A2 for activation of NADPH-oxidase. Potential upstream components of phospholipase A2 activation were investigated. Angiotensin II stimulated a dose and time-dependent activation of the cytosolic tyrosine kinase, Pyk2, and the MAP-kinases, ERK 1/2 and p38, in differentiated PLB-985 cells. Our results demonstrate the ability of angiotensin II to stimulate phagocytic cells and suggest a possible role of these cells in the pathology of hypertensive disease via the formation of inflammatory mediators.

This content is only available as a PDF.
You do not currently have access to this article.